ConductScience.org, home

Trial · NCT04189133

Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men

NCT04189133, Phase 2, Unknown, Azienda Ospedaliero-Universitaria di Modena

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men. Trials, record NCT04189133. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04189133

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men
NCT number
NCT04189133
Status
Unknown
Phases
Phase 2
Enrollment
32 participants, estimated
Lead sponsor
Azienda Ospedaliero-Universitaria di Modena
Conditions
Acquired Hypogonadotropic Hypogonadism
Interventions
Lutropin alfa, Human chorionic gonadotropin
First posted
2019-12-06
Last updated
2023-07-20

Source ClinicalTrials.gov

Registered outcomes38

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryTestosterone2 weeks after treatment starttotal testosterone serum levels
PrimaryTestosterone4 weeks after treatment starttotal testosterone serum levels
PrimaryTestosterone6 weeks after treatment starttotal testosterone serum levels
PrimaryTestosterone8 weeks after treatment starttotal testosterone serum levels
SecondaryInhibin B2 weeks after treatment startInhibin B serum levels
SecondaryInhibin B4 weeks after treatment startInhibin B serum levels
SecondaryInhibin B6 weeks after treatment startInhibin B serum levels
SecondaryInhibin B8 weeks after treatment startInhibin B serum levels
SecondaryFree testosterone2 weeks after treatment startFree testosterone serum levels
SecondaryFree testosterone4 weeks after treatment startFree testosterone serum levels

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers8

The papers the trial lists on ClinicalTrials.gov.

PMIDListed asSource
23071612BACKGROUNDPubMed
25376649BACKGROUNDPubMed
28067604BACKGROUNDPubMed
28252213BACKGROUNDPubMed
28424471BACKGROUNDPubMed
28452938BACKGROUNDPubMed
28620352BACKGROUNDPubMed
28937611BACKGROUNDPubMed

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT04189133

GET https://conductscience.org/api/trials/v1/NCT04189133/registered?page=2